89-005-473
granulin (B01), Mouse anti-Human, Polyclonal Antibody, Abnova™
Manufacturer: Abnova Corporation
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 89-005-473-Each-of-1 | In Stock | ₹ 42,898.00 |
89-005-473 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 42,898.00
GST (18%): ₹ 7,721.64
Total Price: ₹ 50,619.64
Antigen
granulin
Classification
Polyclonal
Description
Mouse polyclonal antibody raised against a full-length human GRN protein.
Gene
GRN
Gene Alias
GEP/GP88/PCDGF/PEPI/PGRN
Host Species
Mouse
Quantity
50 μL
Research Discipline
Cell Cycle
Primary or Secondary
Primary
Target Species
Human
Form
Serum
Applications
Immunofluorescence, Western Blot
Conjugate
Unconjugated
Formulation
No additive
Gene Accession No.
NM_002087
Gene Symbols
GRN
Immunogen
GRN (NP_002078, 1 a.a. ∼ 593 a.a) full-length human protein.
Regulatory Status
RUO
Whole Molecule
Yes
Gene ID (Entrez)
2896
Content And Storage
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Related Products
Description
- Granulins are a family of secreted, glycosylated peptides that are cleaved from a single precursor protein with 7.5 repeats of a highly conserved 12-cysteine granulin/epithelin motif
- The 88kDa precursor protein, progranulin, is also called proepithelin and PC cell-derived growth factor
- Cleavage of the signal peptide produces mature granulin which can be further cleaved into a variety of active, 6kDa peptides
- These smaller cleavage products are named granulin A, granulin B, granulin C, etc
- Epithelins 1 and 2 are synonymous with granulins A and B, respectively
- Both the peptides and intact granulin protein regulate cell growth
- However, different members of the granulin protein family may act as inhibitors, stimulators, or have dual actions on cell growth
- Granulin family members are important in normal development, wound healing, and tumorigenesis
- [provided by RefSeq Sequence: MWTLVSWVALTAGLVAGTRCPDGQFCPVACCLDPGGASYSCCRPLLDKWPTTLSRHLGGPCQVDAHCSAGHSCIFTVSGTSSCCPFPEAVACGDGHHCCPRGFHCSADGRSCFQRSGNNSVGAIQCPDSQFECPDFSTCCVMVDGSWGCCPMPQASCCEDRVHCCPHGAFCDLVHTRCITPTGTHPLAKKLPAQRTNRAVALSSSVMCPDARSRCPDGSTCCELPSGKYGCCPMPNATCCSDHLHCCPQDTVCDLIQSKCLSKENATTDLLTKLPAHTVGDVKCDMEVSCPDGYTCCRLQSGAWGCCPFTQAVCCEDHIHCCPAGFTCDTQKGTCEQGPHQVPWMEKAPAHLSLPDPQALKRDVPCDNVSSCPSSDTCCQLTSGEWGCCPIPEAVCCSDHQHCCPQGYTCVAEGQCQRGSEIVAGLEKMPARRASLSHPRDIGCDQHTSCPVGQTCCPSLGGSWACCQLPHAVCCEDRQHCCPAGYTCNVKARSCEKEVVSAQPATFLARSPHVGVKDVECGEGHFCHDNQTCCRDNRQGWACCPYRQGVCCADRRHCCPAGFRCAARGTKCLRREAPRWDAPLRDPALRQLL